202 related articles for article (PubMed ID: 9771482)
1. Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas.
Franchi A; Arganini L; Baroni G; Calzolari A; Capanna R; Campanacci D; Caldora P; Masi L; Brandi ML; Zampi G
J Pathol; 1998 Jul; 185(3):284-9. PubMed ID: 9771482
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
Masi L; Malentacchi C; Campanacci D; Franchi A
Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression.
Kloen P; Gebhardt MC; Perez-Atayde A; Rosenberg AE; Springfield DS; Gold LI; Mankin HJ
Cancer; 1997 Dec; 80(12):2230-9. PubMed ID: 9404699
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
5. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
Cardillo MR; Yap E
J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
[TBL] [Abstract][Full Text] [Related]
7. Evidence for transforming growth factor-beta expression in human leptomeningeal cells and transforming growth factor-beta-like activity in human cerebrospinal fluid.
Johnson MD; Gold LI; Moses HL
Lab Invest; 1992 Sep; 67(3):360-8. PubMed ID: 1328762
[TBL] [Abstract][Full Text] [Related]
8. Determination of transforming growth factor beta 1 mRNA expression in breast carcinomas by in situ hybridization.
Walker RA; Gallacher B
J Pathol; 1995 Oct; 177(2):123-7. PubMed ID: 7490677
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic analysis of TGF-beta1 in ovarian neoplasia.
Cardillo MR; Yap E; Castagna G
J Exp Clin Cancer Res; 1997 Mar; 16(1):49-56. PubMed ID: 9148861
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma oncogene expression detected by in situ hybridization.
Wang H; Rodgers WH; Chmell MJ; Svitek C; Schwartz HS
J Orthop Res; 1995 Sep; 13(5):671-8. PubMed ID: 7472745
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta isoform expression during bovine ovarian antral follicle development.
Nilsson EE; Doraiswamy V; Skinner MK
Mol Reprod Dev; 2003 Nov; 66(3):237-46. PubMed ID: 14502602
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of cytokines in rat osteosarcoma and malignant fibrous histiocytoma cell lines induced by 4-(hydroxyamino)quinoline-1-oxide.
Honoki K; Tsujiuchi T; Sasaki Y; Tsutsumi M; Morishita T; Kido A; Miyauchi Y; Mii Y; Takakura Y; Konishi Y
Mol Carcinog; 2002 Feb; 33(2):81-7. PubMed ID: 11813300
[TBL] [Abstract][Full Text] [Related]
15. Significance of changes in transforming growth factor-beta mRNA levels in autogenous vein grafts.
You WJ; Xiao MD; Yuan ZX
Chin Med J (Engl); 2004 Jul; 117(7):1060-5. PubMed ID: 15265383
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of osteogenic factors associated with osteoinductivity of human osteosarcoma cell lines.
Yu Y; Harris RI; Yang JL; Anderson HC; Walsh WR
J Biomed Mater Res A; 2004 Jul; 70(1):122-8. PubMed ID: 15174116
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study.
Cardillo MR; Yap EP
Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
19. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
Joyce NC; Harris DL; Mello DM
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]